Photonic BioImaging is a Unit of Technology and Service (UTechS) providing optical imaging expertise in life sciences and especially their application in studies on infectious biology.
Our activities include service rendering, training, technology-driven research and technology development. They are highly multi-disciplined, and collaborative, with the mission goal focused on the use of quantitative imaging and analysis to understand the processes of cell/tissue-biology, and their usurpation by infection and disease. The R&D is founded upon the need to develop optical imaging methods that bring new understanding of host-pathogen interactions and in situ high-content imaging techniques and their application to infection, cell biology, cellular microbiology, and microbiology. We work on novel techniques extrapolating quantitative information on spatiotemporal dynamics in situ and we push the limits of existing approaches aiming to enhance their performance thereby broadening their experimental utility.
Practical Information
We are part of the C2RT (Center for Technological Resources and Research), a center gathering the Technology and Service units (UTechS) and the technological core facilities of the campus. As such we follow the common guidelines and good practices.
If you did not find what you were looking for, please check out the C2RT booklet
Instrument booking, training/project request :
PPMS Booking
(intranet access only)
Open Desk :
The Photonic BioImaging team (Imagopole) offers a bi-weekly open-desk.The goal of the open-desk is to make the PBI engineers available for informal discussions about your forthcoming projects, or any imaging-related question you might have. There is no need to schedule an appointment, just come with your questions. Open-desks are planned to happen every two weeks, same place same time (2:00pm to 3:30 pm , in the Centre François Jacob atrium).
Planned Opendesk/initial training schedule
- Due to the current pandemic situation, Please contact us :
pbi.contact@pasteur.fr
Feedback / Comments
